Anti-ASAP1 monoclonal antibody

Pre-made anti-ASAP1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to ASAP1/ASAP1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2361-Ab-1/ GM-Tg-hg-IP2361-Ab-2Anti-Human ASAP1 monoclonal antibodyHuman
GM-Tg-rg-IP2361-Ab-1/ GM-Tg-rg-IP2361-Ab-2Anti-Rat ASAP1 monoclonal antibodyRat
GM-Tg-mg-IP2361-Ab-1/ GM-Tg-mg-IP2361-Ab-2Anti-Mouse ASAP1 monoclonal antibodyMouse
GM-Tg-cynog-IP2361-Ab-1/ GM-Tg-cynog-IP2361-Ab-2Anti-Cynomolgus/ Rhesus macaque ASAP1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2361-Ab-1/ GM-Tg-felg-IP2361-Ab-2Anti-Feline ASAP1 monoclonal antibodyFeline
GM-Tg-cang-IP2361-Ab-1/ GM-Tg-cang-IP2361-Ab-2Anti-Canine ASAP1 monoclonal antibodyCanine
GM-Tg-bovg-IP2361-Ab-1/ GM-Tg-bovg-IP2361-Ab-2Anti-Bovine ASAP1 monoclonal antibodyBovine
GM-Tg-equg-IP2361-Ab-1/ GM-Tg-equg-IP2361-Ab-2Anti-Equine ASAP1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2361-Ab-1/ GM-Tg-hg-IP2361-Ab-2; GM-Tg-rg-IP2361-Ab-1/ GM-Tg-rg-IP2361-Ab-2;
GM-Tg-mg-IP2361-Ab-1/ GM-Tg-mg-IP2361-Ab-2; GM-Tg-cynog-IP2361-Ab-1/ GM-Tg-cynog-IP2361-Ab-2;
GM-Tg-felg-IP2361-Ab-1/ GM-Tg-felg-IP2361-Ab-2; GM-Tg-cang-IP2361-Ab-1/ GM-Tg-cang-IP2361-Ab-2;
GM-Tg-bovg-IP2361-Ab-1/ GM-Tg-bovg-IP2361-Ab-2; GM-Tg-equg-IP2361-Ab-1/ GM-Tg-equg-IP2361-Ab-2
Products NameAnti-ASAP1 monoclonal antibody
Formatmab
Target NameASAP1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-ASAP1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2361-Ag-1Recombinant multi-species ASAP1/ AMAP1/ CENTB4 protein


    Target information

    Target IDGM-IP2361
    Target NameASAP1
    Gene ID50807,13196,314961,695681,482044,101091998,327705,100068654
    Gene Symbol and SynonymsAMAP1,ASAP1,CENTB4,DDEF1,DEF-1,mKIAA1249,PAG2,PAP,s19,ZG14P
    Uniprot AccessionQ9ULH1,Q1AAU6,O97902
    Uniprot Entry NameASAP1_HUMAN,ASAP1_RAT,ASAP1_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000153317
    Target ClassificationN/A

    The target: ASAP1, gene name: ASAP1, also named as AMAP1, CENTB4, DDEF1, PAG2, PAP, ZG14P. This gene encodes an ADP-ribosylation factor (ARF) GTPase-activating protein. The GTPase-activating activity is stimulated by phosphatidylinositol 4,5-biphosphate (PIP2), and is greater towards ARF1 and ARF5, and lesser for ARF6. This gene maybe involved in regulation of membrane trafficking and cytoskeleton remodeling. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.